Wolverine Trading
AXDX

Wolverine Trading’s Accelerate Diagnostics AXDX Stock Holding History

Wolverine Trading’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,720
Closed -$42K – 3968
2022
Q3 		$42K Buy
+2,720
New +$45K ﹤0.01% 4192
2021
Q2 		– Sell
-1,190
Closed -$97K – 5924
2021
Q1 		$97K Buy
+1,190
New +$121K ﹤0.01% 5443
2020
Q3 		– Sell
-1,120
Closed -$162K – 4480
2020
Q2 		$162K Buy
+1,120
New +$110K ﹤0.01% 3941
2020
Q1 		– Sell
-1,440
Closed -$240K – 4599
2019
Q4 		$240K Sell
1,440
-1,080
-43% -$178K ﹤0.01% 3846
2019
Q3 		$477K Buy
2,520
+600
+31% +$116K ﹤0.01% 2678
2019
Q2 		$439K Sell
1,920
-2,250
-54% -$440K ﹤0.01% 2857
2019
Q1 		$877K Sell
4,170
-2,160
-34% -$405K ﹤0.01% 2210
2018
Q4 		$746K Buy
6,330
+5,340
+539% +$791K ﹤0.01% 2245
2018
Q3 		$227K Buy
+990
New +$219K ﹤0.01% 4095
2017
Q4 		– Sell
-1,690
Closed -$379K – 4867
2017
Q3 		$379K Buy
+1,690
New +$415K ﹤0.01% 2947
2016
Q4 		– Sell
-3,570
Closed -$941K – 4423
2016
Q3 		$941K Buy
3,570
+450
+14% +$99.6K ﹤0.01% 1912
2016
Q2 		$444K Buy
+3,120
New +$418K ﹤0.01% 2336

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wolverine Trading's AXDX Position: Q2 2023 in Review

Wolverine Trading sold out of Accelerate Diagnostics (AXDX) in Q2 2023, closing a stake of 1,329 shares — an estimated $9K sold.

Wolverine Trading first reported a position in AXDX in Q1 2017 and held it in 14 quarters. The position peaked at $530K in Q2 2017. 51 funds tracked by Wall St. Rank hold AXDX as of Q2 2023.

  • Wolverine Trading reported no remaining Accelerate Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 1,329 Accelerate Diagnostics shares in Q2 2023, an estimated $9K.
  • Wolverine Trading first reported a position in Accelerate Diagnostics in Q1 2017 and held it in 14 quarters.
  • Wolverine Trading's Accelerate Diagnostics position peaked at $530K in Q2 2017.
  • 51 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.